CG Oncology appoints Christina Rossi to board; director Simone Song resigns

CG Oncology, Inc.

Christina Rossi appointed to Board as Class II director effective November 24, 2025.
Rossi receives $45K annual retainer and initial option award of 20,889 shares vesting over 3 years.
Simone Song resigned from Board and all committees effective November 22, 2025; no disagreement cited.
Song served on Audit Committee and chaired Compensation Committee; no replacement committees named.
Standard indemnification agreement entered with Rossi; no transactions requiring disclosure.

item 5.02

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-25-298160
form_type: 8-K
ticker: CGON
cik: 0001991792
company_name: CG Oncology, Inc.
filed_at: 2025-11-26T23:59:59+00:00
discovered_at: 2026-05-14T18:02:41.227437+00:00
generated_at: 2026-05-16T16:40:10.217247+00:00
sec_items: ["5.02"]
event_type: leadership
sentiment: neutral
materiality_score: 0.3
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-25-298160
json_url: https://secwatch.observer/filing/0001193125-25-298160.json
markdown_url: https://secwatch.observer/filing/0001193125-25-298160.md
text_url: https://secwatch.observer/filing/0001193125-25-298160.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1991792/000119312525298160/0001193125-25-298160-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1991792/000119312525298160/ck0001991792-20251122.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-25-298160

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.